| Year |
Citation |
Score |
| 2015 |
Zawada WM, Mrak RE, Biedermann J, Palmer QD, Gentleman SM, Aboud O, Griffin WS. Loss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation. Acta Neuropathologica Communications. 3: 9. PMID 25645462 DOI: 10.1186/S40478-015-0189-Z |
0.631 |
|
| 2013 |
Topchiy E, Panzhinskiy E, Griffin WS, Barger SW, Das M, Zawada WM. Nox4-generated superoxide drives angiotensin II-induced neural stem cell proliferation. Developmental Neuroscience. 35: 293-305. PMID 23751520 DOI: 10.1159/000350502 |
0.344 |
|
| 2011 |
Zawada WM, Banninger GP, Thornton J, Marriott B, Cantu D, Rachubinski AL, Das M, Griffin WS, Jones SM. Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade. Journal of Neuroinflammation. 8: 129. PMID 21975039 DOI: 10.1186/1742-2094-8-129 |
0.636 |
|
| 2008 |
Ahmadi FA, Grammatopoulos TN, Poczobutt AM, Jones SM, Snell LD, Das M, Zawada WM. Dopamine selectively sensitizes dopaminergic neurons to rotenone-induced apoptosis. Neurochemical Research. 33: 886-901. PMID 17992568 DOI: 10.1007/S11064-007-9532-5 |
0.717 |
|
| 2007 |
Grammatopoulos TN, Jones SM, Ahmadi FA, Hoover BR, Snell LD, Skoch J, Jhaveri VV, Poczobutt AM, Weyhenmeyer JA, Zawada WM. Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra. Molecular Neurodegeneration. 2: 1. PMID 17224059 DOI: 10.1186/1750-1326-2-1 |
0.686 |
|
| 2005 |
Grammatopoulos TN, Ahmadi F, Jones SM, Fariss MW, Weyhenmeyer JA, Zawada WM. Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death. Brain Research. 1045: 64-71. PMID 15910763 DOI: 10.1016/J.Brainres.2005.03.038 |
0.715 |
|
| 2004 |
Miranda M, Sorkina T, Grammatopoulos TN, Zawada WM, Sorkin A. Multiple molecular determinants in the carboxyl terminus regulate dopamine transporter export from endoplasmic reticulum. The Journal of Biological Chemistry. 279: 30760-70. PMID 15128747 DOI: 10.1074/Jbc.M312774200 |
0.435 |
|
| 2003 |
Ahmadi FA, Linseman DA, Grammatopoulos TN, Jones SM, Bouchard RJ, Freed CR, Heidenreich KA, Zawada WM. The pesticide rotenone induces caspase-3-mediated apoptosis in ventral mesencephalic dopaminergic neurons. Journal of Neurochemistry. 87: 914-21. PMID 14622122 DOI: 10.1046/J.1471-4159.2003.02068.X |
0.715 |
|
| 2003 |
Crews FT, Miller MW, Ma W, Nixon K, Zawada WM, Zakhari S. Neural stem cells and alcohol. Alcoholism, Clinical and Experimental Research. 27: 324-35. PMID 12605082 DOI: 10.1097/01.Alc.0000052581.46630.C5 |
0.332 |
|
| 2002 |
Zhou W, Schaack J, Zawada WM, Freed CR. Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture. Brain Research. 926: 42-50. PMID 11814405 DOI: 10.1016/S0006-8993(01)03292-9 |
0.487 |
|
| 2001 |
Ourednik V, Ourednik J, Flax JD, Zawada WM, Hutt C, Yang C, Park KI, Kim SU, Sidman RL, Freed CR, Snyder EY. Segregation of human neural stem cells in the developing primate forebrain. Science (New York, N.Y.). 293: 1820-4. PMID 11474066 DOI: 10.1126/Science.1060580 |
0.32 |
|
| 2001 |
Clarkson ED, Zawada WM, Bell KP, Esplen JE, Choi PK, Heidenreich KA, Freed CR. IGF-I and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands. Experimental Neurology. 168: 183-91. PMID 11170733 DOI: 10.1006/Exnr.2000.7593 |
0.455 |
|
| 2001 |
Zawada WM, Meintzer MK, Rao P, Marotti J, Wang X, Esplen JE, Clarkson ED, Freed CR, Heidenreich KA. Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons. Brain Research. 891: 185-96. PMID 11164822 DOI: 10.1016/S0006-8993(00)02965-6 |
0.578 |
|
| 1998 |
Clarkson ED, Zawada WM, Adams FS, Bell KP, Freed CR. Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats. Brain Research. 806: 60-8. PMID 9739108 DOI: 10.1016/S0006-8993(98)00717-3 |
0.482 |
|
| 1998 |
Zawada WM, Cibelli JB, Choi PK, Clarkson ED, Golueke PJ, Witta SE, Bell KP, Kane J, Ponce de Leon FA, Jerry DJ, Robl JM, Freed CR, Stice SL. Somatic cell cloned transgenic bovine neurons for transplantation in parkinsonian rats. Nature Medicine. 4: 569-74. PMID 9585230 DOI: 10.1038/Nm0598-569 |
0.408 |
|
| 1998 |
Zawada WM, Zastrow DJ, Clarkson ED, Adams FS, Bell KP, Freed CR. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Research. 786: 96-103. PMID 9554968 DOI: 10.1016/S0006-8993(97)01408-X |
0.56 |
|
| 1997 |
Clarkson ED, Zawada WM, Freed CR. GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro. Cell and Tissue Research. 289: 207-10. PMID 9211823 DOI: 10.1007/s004410050867 |
0.51 |
|
| 1996 |
Kaddis FG, Zawada WM, Schaack J, Freed CR. Conditioned medium from aged monkey fibroblasts stably expressing GDNF and BDNF improves survival of embryonic dopamine neurons in vitro. Cell and Tissue Research. 286: 241-7. PMID 8854893 DOI: 10.1007/S004410050693 |
0.501 |
|
| 1996 |
Zawada WM, Kirschman DL, Cohen JJ, Heidenreich KA, Freed CR. Growth factors rescue embryonic dopamine neurons from programmed cell death. Experimental Neurology. 140: 60-7. PMID 8682180 DOI: 10.1006/Exnr.1996.0115 |
0.545 |
|
| 1995 |
Clarkson ED, Zawada WM, Freed CR. GDNF reduces apoptosis in dopaminergic neurons in vitro. Neuroreport. 7: 145-9. PMID 8742438 |
0.59 |
|
| Show low-probability matches. |